Ultralife (ULBI) Cost of Revenue (2010 - 2026)

Ultralife's Cost of Revenue history runs 17 years deep, the most recent figure standing at $37.3 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 1.75% year-over-year to $37.3 million; the TTM figure through Mar 2026 stood at $144.5 million (up 49.63% YoY), while the FY2025 annual figure was $145.1 million, up 18.83% from the prior year.
• Cost of Revenue for Q1 2026 stood at $37.3 million, up from $36.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $38.0 million in Q1 2025, with the low at $120000.0 in Q4 2024.
• The 5-year median for Cost of Revenue is $30.5 million (2024), against an average of $29.0 million.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue slumped 99.64% in 2024, then jumped 30254.17% in 2025.
• Ultralife's Cost of Revenue stood at $28.0 million in 2022, then increased by 18.27% to $33.1 million in 2023, then plunged by 99.64% to $120000.0 in 2024, then surged by 30254.17% to $36.4 million in 2025, then rose by 2.5% to $37.3 million in 2026.
• Business Quant data shows ULBI's Cost of Revenue at $37.3 million in Q1 2026, $36.4 million in Q4 2025, and $33.8 million in Q3 2025.